Literature DB >> 8572325

Effect of blood pressure changes on air flow dynamics in the upper airway of the decerebrate cat.

A H Mayor1, A R Schwartz, J A Rowley, S J Willey, M B Gillespie, P L Smith, J L Robotham.   

Abstract

BACKGROUND: Previous studies suggest that upper airway neuromuscular activity can be affected by changes in blood pressure via a baroreceptor-mediated mechanism. It was hypothesized that increases in blood pressure would increase upper airway collapsibility predisposing to airway obstruction at a flow-limiting site in the hypopharynx.
METHODS: To examine the effect of blood pressure on upper airway function, maximal inspiratory air flow was determined through the isolated feline upper airway before, during, and after intravenous infusion of phenylephrine (10-20 micrograms.kg-1.min) in six decerebrate, tracheotomized cats. Inspiratory flow, hypopharyngeal pressure, and pressure at the site of pharyngeal collapse were recorded as hypopharyngeal pressure was rapidly decreased to achieve inspiratory flow limitation in the isolated upper airway. Pressure-flow relationships were used to determine maximal inspiratory air flow and its mechanical determinants, the upper airway critical pressure (a measure of pharyngeal collapsibility), and the nasal resistance upstream to the site of flow limitation.
RESULTS: An increased mean arterial blood pressure of 71 +/- 16 mmHg (mean +/- SD) was associated with significant decrease in maximal inspiratory air flow from 147 +/- 38 ml/s to 115 +/- 27 ml.sec-1 (P < 0.01). The decrease in maximal inspiratory air flow was associated with an increase in upper airway critical pressure from -8.1 +/- 3.8 to -5.7 +/- 3.7 cm H2O (p < 0.02), with no significant change in nasal resistance. When blood pressure was decreased to baseline by discontinuing the phenylephrine infusion, maximal inspiratory air flow and upper airway critical pressure returned to their baseline values.
CONCLUSIONS: Increased blood pressure increased the severity of upper airway air flow obstruction by increasing pharyngeal collapsibility. Previous studies relating baroreceptor activity to neuromuscular regulation of upper airway tone, are consistent with this effect being mediated by afferent activity from baroreceptors. These findings warrant further study because they suggest the possibility that upper airway obstruction in postoperative patients could either be caused or exacerbated by an increase in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572325     DOI: 10.1097/00000542-199601000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  Effect of Antihypertensive Medications on the Severity of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Kiran Khurshid; Jonathan Yabes; Patricia M Weiss; Sushma Dharia; Lee Brown; Mark Unruh; Manisha Jhamb
Journal:  J Clin Sleep Med       Date:  2016-08-15       Impact factor: 4.062

2.  The effect of rapid eye movement (REM) sleep on upper airway mechanics in normal human subjects.

Authors:  J A Rowley; B R Zahn; M A Babcock; M S Badr
Journal:  J Physiol       Date:  1998-08-01       Impact factor: 5.182

3.  The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob/ob mouse.

Authors:  H Pho; A B Hernandez; R S Arias; E B Leitner; S Van Kooten; J P Kirkness; H Schneider; P L Smith; V Y Polotsky; A R Schwartz
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

Review 4.  Systemic hypertension in obstructive sleep apnea.

Authors:  Carolina Lombardi; Martino F Pengo; Gianfranco Parati
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Impairment of the baroreflex control of human respiratory resistance with age.

Authors:  M Tafil-Klawe; J J Klawe; P Zalewski; A Lewandowski
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

6.  Reflex influence of carotid baroreceptor inactivation on respiratory resistance in humans.

Authors:  J J Klawe; M Tafil-Klawe; A Lewandowski; P Zalewski
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.